Menu
1-702-720-6310 info@microcapspecualtors.com

Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains? – Investor’s Business Daily


Investor’s Business Daily

Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?
Investor’s Business Daily
The biotech industry is slated to close 2016 down by double digits, but five top performers — a cancer specialist rivaling AstraZeneca (AZN) and AbbVie (ABBV), and four 2016 IPOs — are prepping to end the year with triple-digit gains. No. 12 biotech

and more »

Search